SCHEMBL2570520

SCHEMBL2570520

Cc1cc(Cl)ccc1NC(=O)Nc1cn(CC2CC2)c(OC(=O)O)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
ALDH1A1 P00352 2/20 0.38
HTT P42858 2/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
MAPT P10636 6/20 0.37
LMNA P02545 1/20 0.37
ATM Q13315 1/20 0.37
POLB P06746 1/20 0.37
MDM2 Q00987 1/20 0.37
KDR P35968 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TP53 P04637 1/20 0.36
IDH1 O75874 1/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2568709 0.90 MEN1 (0.37) MEN1KMT2AALDH1A1HTTMAPT
SCHEMBL1594449 0.85 MEN1 (0.41) MEN1KMT2AALDH1A1HTTCYP2D6
SCHEMBL2572026 0.85 P2RX7 (0.48) KMT2AMAPTLMNAPOLBKDR
SCHEMBL1594765 0.84 TP53 (0.40) MEN1KMT2AALDH1A1HTTMAPT
SCHEMBL2568640 0.84 MAPT (0.39) MEN1KMT2AALDH1A1MAPTLMNA
SCHEMBL2569125 0.84 MAPT (0.39) MEN1KMT2AALDH1A1HTTMAPT
SCHEMBL2572466 0.83 MAPK1 (0.37) MEN1KMT2ANPSR1MAPTATM
SCHEMBL2570875 0.83 MAPK1 (0.37) MEN1KMT2ANPSR1MAPTATM
SCHEMBL2565938 0.81 ALOX5 (0.40) ALDH1A1HTTMAPTPOLBNPC1
SCHEMBL2567127 0.80 GRIK1 (0.42) MEN1KMT2AHTTCYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1732901-B1 ANTIVIRAL 4-AMINOCARBONYLAMINO-SUBSTITUTED IMIDAZOLE COMPOUND AICURIS GMBH & CO KG (DE) 2011-11-02 EP disclosed
EP-1853582-B1 HETEROCYCLYLAMIDE-SUBSTITUTED IMIDAZOLES AICURIS GMBH & CO KG (DE) 2009-10-21 EP disclosed
EP-1853582-A2 HETEROCYCLYLAMIDE-SUBSTITUTED IMIDAZOLES AiCuris GmbH & Co. KG (DE) 2007-11-14 EP disclosed
EP-1732901-A1 ANTIVIRAL 4-AMINOCARBONYLAMINO-SUBSTITUTED IMIDAZOLE COMPOUND Bayer HealthCare AG (DE) 2006-12-20 EP disclosed
WO-2006089664-A2 HETEROCYCLYLAMIDE-SUBSTITUTED IMIDAZOLES AICURIS GMBH & CO. KG (DE) 2006-08-31 WO disclosed
WO-2005092865-A1 ANTIVIRAL 4-AMINOCARBONYLAMINO-SUBSTITUTED IMIDAZOLE COMPOUND BAYER HEALTHCARE AG (DE) 2005-10-06 WO disclosed